FR2423490A1 - Nouveaux 4-oxo-4h-pyrido(1,2-a)pyrimidine-3-n-(1h-tetrazol-5-yl) carboxamides eventuellement substitues, leur procede de production et medicament les contenant - Google Patents
Nouveaux 4-oxo-4h-pyrido(1,2-a)pyrimidine-3-n-(1h-tetrazol-5-yl) carboxamides eventuellement substitues, leur procede de production et medicament les contenantInfo
- Publication number
- FR2423490A1 FR2423490A1 FR7907971A FR7907971A FR2423490A1 FR 2423490 A1 FR2423490 A1 FR 2423490A1 FR 7907971 A FR7907971 A FR 7907971A FR 7907971 A FR7907971 A FR 7907971A FR 2423490 A1 FR2423490 A1 FR 2423490A1
- Authority
- FR
- France
- Prior art keywords
- tetrazol
- pyrido
- oxo
- new
- pyrimidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 1H-TETRAZOL-5-YL Chemical class 0.000 title 1
- 150000003857 carboxamides Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 230000003266 anti-allergic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/892,714 US4192944A (en) | 1978-04-03 | 1978-04-03 | Optionally substituted 4-oxo-4H-pyrido[1,2-a]pyrimidine-3-N-(1H-tetrazol-4-yl)carboxamides and their use as antiallergy agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2423490A1 true FR2423490A1 (fr) | 1979-11-16 |
| FR2423490B1 FR2423490B1 (enExample) | 1982-03-19 |
Family
ID=25400392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7907971A Granted FR2423490A1 (fr) | 1978-04-03 | 1979-03-29 | Nouveaux 4-oxo-4h-pyrido(1,2-a)pyrimidine-3-n-(1h-tetrazol-5-yl) carboxamides eventuellement substitues, leur procede de production et medicament les contenant |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4192944A (enExample) |
| JP (1) | JPS54141797A (enExample) |
| BE (1) | BE875246A (enExample) |
| CA (1) | CA1117112A (enExample) |
| CH (1) | CH643256A5 (enExample) |
| DE (1) | DE2913295A1 (enExample) |
| DK (1) | DK153485C (enExample) |
| FR (1) | FR2423490A1 (enExample) |
| GB (1) | GB2019836B (enExample) |
| IE (1) | IE48278B1 (enExample) |
| IT (1) | IT1116537B (enExample) |
| LU (1) | LU81107A1 (enExample) |
| NL (1) | NL7902444A (enExample) |
| SE (1) | SE440652B (enExample) |
| ZA (1) | ZA791525B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4495189A (en) * | 1975-11-27 | 1985-01-22 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. | Condensed pyrimidines |
| HU173438B (hu) * | 1975-11-27 | 1979-05-28 | Chinoin Gyogyszer Es Vegyeszet | Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom |
| IE51802B1 (en) * | 1979-12-03 | 1987-04-01 | Fujisawa Pharmaceutical Co | Quinazoline derivatives,processes for their preparation and pharmaceutical compositions containing them |
| CA1157858A (en) | 1979-12-03 | 1983-11-29 | Ikuo Ueda | Quinazoline derivatives |
| JPS63183581A (ja) * | 1985-10-03 | 1988-07-28 | Tokyo Tanabe Co Ltd | ピリド〔１，２−ａ〕ピリミジン誘導体、その製造法及びそれを有効成分とするアレルギ−疾患治療薬 |
| HU201551B (en) * | 1988-02-03 | 1990-11-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing 4-oxo-4h-pyrido(1,2-a)pyrimidine-3-carboxylic acid amide derivatives and pharmaceutical compositions comprising same |
| US6295995B1 (en) * | 2000-04-07 | 2001-10-02 | Irene D. Ewaka | Permanently covered rigid or semi-rigid mounting piece for an article of fashion |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2319363A1 (fr) * | 1975-08-01 | 1977-02-25 | Pfizer | N-(5-tetrazolyl)-1-oxo-1h-6-alcoxypyrimido (1,2-a) quinoleine-2-carboxamides anti-allergiques et intermediaires appropries |
| FR2401159A1 (fr) * | 1977-05-25 | 1979-03-23 | Bristol Myers Co | Derives de 3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)pyrimidine-4-one, leur procede de preparation et leur activite therapeutique |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3072485A (en) * | 1960-08-24 | 1963-01-08 | Eastman Kodak Co | Optically sensitized azido polymers for photomechanical resist compositions |
| DE1795769C3 (de) * | 1966-11-02 | 1978-11-02 | Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt, Budapest | 6,7,8,9-Tetrahydro-2H-pyrido [Ua] pyrimidinderivate, deren Salze mit Säuren und quaternäre Methosalze, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel |
| US3960847A (en) * | 1972-04-17 | 1976-06-01 | E. R. Squibb & Sons, Inc. | 9-Substituted-4-oxopyrido(1,2-α)pyrimidine-3-carboxylic acids and derivatives thereof |
| US3929787A (en) * | 1974-04-22 | 1975-12-30 | Squibb & Sons Inc | 6,7,8,9-Tetrahydro-pyrido(1,2-a)pyrimidin-4-ones |
| US4017625A (en) * | 1975-08-01 | 1977-04-12 | Pfizer Inc. | Anti-allergic N-(5-tetrazolyl)-1-oxo-1H-6-alkoxypyrimido-[1,2-a]quinoline-2-carboxamides and intermediates therefor |
| HU173438B (hu) * | 1975-11-27 | 1979-05-28 | Chinoin Gyogyszer Es Vegyeszet | Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom |
-
1978
- 1978-04-03 US US05/892,714 patent/US4192944A/en not_active Expired - Lifetime
-
1979
- 1979-03-15 GB GB7909146A patent/GB2019836B/en not_active Expired
- 1979-03-29 DK DK130079A patent/DK153485C/da active
- 1979-03-29 NL NL7902444A patent/NL7902444A/xx not_active Application Discontinuation
- 1979-03-29 FR FR7907971A patent/FR2423490A1/fr active Granted
- 1979-03-30 BE BE0/194348A patent/BE875246A/xx not_active IP Right Cessation
- 1979-03-30 CA CA000324712A patent/CA1117112A/en not_active Expired
- 1979-03-30 ZA ZA791525A patent/ZA791525B/xx unknown
- 1979-04-02 SE SE7902915A patent/SE440652B/sv not_active IP Right Cessation
- 1979-04-02 LU LU81107A patent/LU81107A1/xx unknown
- 1979-04-02 IT IT48569/79A patent/IT1116537B/it active
- 1979-04-03 DE DE19792913295 patent/DE2913295A1/de active Granted
- 1979-04-03 CH CH310379A patent/CH643256A5/de not_active IP Right Cessation
- 1979-04-03 JP JP3942779A patent/JPS54141797A/ja active Granted
- 1979-08-08 IE IE950/79A patent/IE48278B1/en not_active IP Right Cessation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2319363A1 (fr) * | 1975-08-01 | 1977-02-25 | Pfizer | N-(5-tetrazolyl)-1-oxo-1h-6-alcoxypyrimido (1,2-a) quinoleine-2-carboxamides anti-allergiques et intermediaires appropries |
| FR2401159A1 (fr) * | 1977-05-25 | 1979-03-23 | Bristol Myers Co | Derives de 3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)pyrimidine-4-one, leur procede de preparation et leur activite therapeutique |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2019836A (en) | 1979-11-07 |
| GB2019836B (en) | 1982-06-03 |
| DK153485B (da) | 1988-07-18 |
| CH643256A5 (de) | 1984-05-30 |
| IE48278B1 (en) | 1984-11-28 |
| LU81107A1 (fr) | 1979-11-07 |
| SE440652B (sv) | 1985-08-12 |
| FR2423490B1 (enExample) | 1982-03-19 |
| NL7902444A (nl) | 1979-10-05 |
| IE790950L (en) | 1979-10-03 |
| ZA791525B (en) | 1980-11-26 |
| DE2913295C2 (enExample) | 1988-09-22 |
| CA1117112A (en) | 1982-01-26 |
| BE875246A (fr) | 1979-10-01 |
| JPS54141797A (en) | 1979-11-05 |
| SE7902915L (sv) | 1979-10-04 |
| JPS6256874B2 (enExample) | 1987-11-27 |
| DK153485C (da) | 1988-11-21 |
| US4192944A (en) | 1980-03-11 |
| DE2913295A1 (de) | 1979-10-18 |
| DK130079A (da) | 1979-10-04 |
| IT1116537B (it) | 1986-02-10 |
| IT7948569A0 (it) | 1979-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2378763A1 (fr) | Nouveaux derives de 1,4-dihydropyridine substitues en position 2, leur procede de preparation et medicament les contenant | |
| FR2411821A1 (fr) | Nouveaux 1,9-dihydroxyoctahydrophenanthrenes et 1-hydroxyoctahydrophenanthrene-9-ones et medicament les contenant | |
| FR2430939A1 (fr) | Nouveaux derives d'acides (dl)-16-(phenoxy ou phenoxy substitue)-9-ceto- prostatrienoiques, leur procede de production et medicament les contenant | |
| AR028988A1 (es) | Derivados amida, proceso para su preparacion, composicion farmaceutica que los comprende, y su uso en la fabricacion de un medicamento util en el tratamiento de enfermedades o afecciones clinicas mediadas por citoquinas | |
| FR2450832A1 (fr) | Nouveaux 3-(1-imidazolylalkyl) indoles, leur procede de production et composition pharmaceutique les contenant | |
| MA38099A1 (fr) | Des nouveaux composes triazolopyrazines substitues inhibiteurs des brd4 | |
| AR009382A1 (es) | Derivados de acidos orto-sulfonamido aril hidroxamicos como inhibidores de la metaloproteinasa de matriz y tace, composiciones que los contienen y uso delos mismos para la preparacion de un medicamento. | |
| FR2362834A1 (fr) | Nouveaux derives 6-hemicetal ou 6-ceto de prostaglandine, leur procede de preparation et medicament les contenant | |
| TNSN97087A1 (fr) | 4(3h)-quinazolinones 2,3-disubstituees nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| ATE208397T1 (de) | Arylsubstituierte 5,5 verknüpfte aromatische nitroverbindungen als entzündungshemmende wirkstoffe | |
| JPS62205091A (ja) | 新規なリン酸ジエステルならびにその塩、その製造法およびそれを含有する製剤 | |
| KR950702181A (ko) | 20-위치가 변형된 비타민 D계열의 유도체, 이들의 제조 방법, 이 제조 방법을 위한 중간 생성물, 이들 유도체를 함유하는 제약 제제, 및 약제 제조를 위한 이들의 용도(Derivatives in the Vitamin D Series Modified at the 20 Position a Method of Preparing Such Derivatives, Intermediates Used in This Method, Pharmaceutical Preparations Containing the Derivatives and Their Use in the Preparation of Drugs) | |
| BRPI0409427A (pt) | composto, uso do mesmo, composição farmacêutica, método de tratamento de um humano sofrendo de uma doença hiperproliferativa, e, processo para a preparação de um composto ou de um sal, éster ou pró-droga farmaceuticamente aceitáveis do mesmo | |
| FR2423490A1 (fr) | Nouveaux 4-oxo-4h-pyrido(1,2-a)pyrimidine-3-n-(1h-tetrazol-5-yl) carboxamides eventuellement substitues, leur procede de production et medicament les contenant | |
| MX163574B (es) | Procedimiento para preparar una composicion farmaceutica para inhalacion conteniendo un gangliosido | |
| JPS62145019A (ja) | 抗炎症剤 | |
| FR2393577A1 (fr) | Medicament a base d'acide b-(p-halogenophenyl)-g-aminobutyrique destine au traitement de la nevrose d'angoisse | |
| FR2434162A1 (fr) | Nouveaux derives de 4-amino-2-piperidino-quinazoline, leur procede de production et medicament les contenant | |
| FR2422640A1 (fr) | Nouvelles morphinane-6-ones a substituant 8b-alkyle, leur procede de production et medicament les contenant | |
| EA200501870A1 (ru) | Новые производные имидазолов, способ их получения и их применение в качестве лекарственного средства | |
| CA2569537A1 (fr) | Utilisation de la betaine pour le traitement des arterites | |
| FR2420346A1 (fr) | Medicaments contenant des alcenylxanthines et leur procede de preparation | |
| FR2404010A1 (fr) | Nouveaux derives de pyrimido-(2,1-a)isoquinoleine, leur procede de production et composition pharmaceutique les contenant | |
| JP5984853B2 (ja) | ジャワニッケイの抽出物、抽出方法、ならびにプロトンポンプダウンレギュレーター、酵素阻害剤および粘膜保護剤としてのそれの使用 | |
| FR2401132A1 (fr) | Nouveaux derives de triphenylbutene-1, leur procede de production et composition pharmaceutique les contenant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |